Chris@NNW, Author at NetworkNewsWire

TuesdayFeb 16, 2021 3:17 pm

Mobius Interactive Ltd. Levels Up with UltraPlay Partnership

UltraPlay provides turn-key platform to reach growing global audience. Esports is now a necessity for gambling operators. Success in eSports lies in ability to pivot, continually improve player experience, and build brand loyalty. Mobius Interactive, an online gaming operator, has partnered with the multi award-winning betting provider UltraPlay (https://nnw.fm/raDUp). This partnership equips Mobius to provide players with access to more than 34 eSports games, live events and mystery jackpots, as well as live and prematch odds. In September 2020, Mobius launched its initial three brands with UltraPlay; this expanded partnership will equip the company to further enhance the player experience in…

TuesdayFeb 16, 2021 3:09 pm

Closing Soon: Fast Flower Farms SPV Investment Opportunity

Fast Flower Farms & The Artisanal Cannabis Connoisseur While cannabis companies have recently raised hundreds of millions in an attempt to bring ‘craft cannabis’ to scale, many consumers prefer cannabis that is cultivated by craft growers rather than large corporations. Enter artisanal cannabis products. Artisanal Products Artisanal products create value via limited production, emphasis on quality, and creation by industry connoisseurs. Artisan flower is grown in small batches and is manicured by hand, unlike commercial flower which is done with machines. Artisanal production combined with superior genetics that have limited market availability increases consumer demand and builds brand loyalty. Video…

TuesdayFeb 16, 2021 2:42 pm

Knightscope’s Autonomous Security Robots Provide Real World Solutions in Era of National Anxiety

The global COVID pandemic, community violence and political strife have all served to batter the national psyche during the past year Journalists and researchers have reported rising levels of depression and anxiety as well as a rising number of people experiencing property and violent crime Knightscope is a company dedicated to building and marketing autonomous security robots (“ASRs”) as a means of helping to make the United States safer Knightscope’s ASR series comes in different models that function from a stationary base or a mobile sentry, serving as a deterrent by 24/7 presence and the technological capability to monitor, record…

TuesdayFeb 16, 2021 2:30 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Outlines 2021 Business Strategies for COVID-19 PCR Testing and Psychedelic Treatments

XPhyto Therapeutics Corp. plans to commercialize its rapid and portable PCR Kit this year to provide point-of-care diagnostics The company is confident about the successful validation of the PCR kit for the European commercial (CE-IVD) approval in Q1 2021 Hugh Rogers, CEO and Director of XPhyto, revealed in the latest news release that the company will make investments and development of psychedelic treatments XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator involved in the development of new pharmaceuticals, diagnostic products, and psychedelic medicine. As a part of its business strategy for the year 2021, the company…

TuesdayFeb 16, 2021 2:15 pm

Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Delineates Parameters and Timeline of Study into Psilocybin-Based Active Treatments

Pure Extract Technologies pursues study into psilocybin active treatments Study to extend for 250-day period, targeting a number of milestones The study is set to be carried out at Toronto Institute of Pharmaceutical Technology, will be supervised by Pure Extracts’ scientific advisor, Dr. Alexander MacGregor Oregon recently voted to legalize psilocybin mushrooms for therapeutic use, a potential legislative movement which may soon be replicated in other jurisdictions Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on the cannabis, hemp, and functional mushroom sectors, has provided investors with an update in regards to its ongoing…

TuesdayFeb 16, 2021 12:49 pm

SRAX Inc. (NASDAQ: SRAX) Sequire Platform Provides Exclusive Access to B. Riley Vision Day Content; Company Announces Closing on BIGtoken Transaction

As host to B. Riley’s Securities’ 2021 Vision Day, SRAX offers event content to Sequire community SRAX CEO states that B. Riley event is “perfect example of our growing Virtual Event Platform capabilities” Definitive agreement between SRAX-created BIGtoken, FPVD closes SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its SaaS platform, concluded its role as the exclusive technology host for B. Riley Securities’ 2021 Vision Day (https://nnw.fm/bM36X); sessions from the event are available exclusively to B. Riley clients and investors on the Sequire platform. The company also announced that its BIGtoken platform closed…

TuesdayFeb 16, 2021 11:38 am

MustGrow Biologics Corp. (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) Plant-Based Biopesticide Achieves 100% Control of Root-Rot Disease in Recent Studies

Most recent tests show MustGrow’s patented biopesticide achieved 100% control over Aphanomyces within 24 hours Plant-based biopesticide uses natural defense mechanism found in mustard seed to control diseases, pests and weeds MustGrow hoping to provide valuable crop-protection tool for pulse-crop farmers MustGrow Biologics (CSE: MGRO) (OTCQX: MGROF) (FRA: 0C0) has announced that its plant-based biopesticide has achieved 100% control of root-rot disease in a recent round of laboratory tests (https://nnw.fm/btlNA). MustGrow, an agriculture biotech company focused on providing natural science-based biological solutions for high-value crops such as fruits and vegetables, is focused on providing natural, science-based biological solutions to replace…

TuesdayFeb 16, 2021 11:25 am

Sharing Services Global Corp. (SHRG) Promotes Elevated Customer-Centric Model

Customers seek out highly personalized buying experiences in 2020 and beyond. Companies looking at what it means to be customer centric, how to create long-lasting relationships. Highly personalized customer service has always been high priority for SHRG. As a new year begins, direct-selling leaders are looking to the future and wondering what trends will stick following the COVID-19 pandemic. Industry experts predict that companies with a strong customer-centric focus will perform the best moving forward, a prediction that bodes well for Sharing Services Global Corporation (OTCQB: SHRG). Sharing Services is committed to elevating the convenience and value of doing business…

TuesdayFeb 16, 2021 9:00 am

Essential E-Learning Ecosystems Move to the Head of the Class

NetworkNewsWire Editorial Coverage: Long before the COVID-19 pandemic, the trend toward digital online learning in both education and business was growing at a steady pace. As the pandemic surged, tens of millions were forced to work from home and college classrooms were shuttered, and the trend turned to a tsunami, leaving many businesses completely unprepared for the new normal. Now both the present and the future of learning and work has moved online, and whole ecosystems must move to e-learning to survive. Demand has surged for customized and scalable online learning products in a single, easy-to-use format. This is the…

FridayFeb 12, 2021 3:23 pm

CNS Pharmaceuticals (NASDAQ: CNSP) Celebrates IND Status, Prepares to Launch Brain Cancer Drug Trials

Brain cancer drug developer CNS Pharmaceuticals is celebrating recent news that the U.S. Food and Drug Administration (“FDA”) granted investigational new drug (“IND”) status to CNS Pharmaceuticals’ leading candidate for fighting glioblastomas Glioblastomas are a class of aggressive brain cancers with no known cure and a median life expectancy of 14 to 16 months following diagnosis The FDA’s decision to grant CNSP’s request for IND status clears the way for the company to begin human clinical trials within the next couple of months The company’s sublicensee partner, WPD Pharmaceuticals, will also prepare a first-ever Phase I trial for drug safety…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Author: Chris@NNW